Published on Sunday February 06, 2022

We are working on the following new projects:

  • We were awarded with two phase IV full-service trials of Nimesulide.
  • We signed four new contracts for BE trials with our Russian sponsor (INN Hymecromone, Apixaban, Dapagliflozinum, Rosuvastatin).
  • Smooth signed contracts for two Paliperidone trials.
  • We signed a contract for medical writing for a cell therapy trial. We are happy to be involved in such a project because there is just one cell product under clinical development in Russia.

We are happy to reach the following milestones in our projects:

  • The enrollment is finished in the Covid-19 vaccine trial. 5000 subjects were randomized for less than 2 months.
  • 50% of the sites were open and 100 subjects were enrolled in the observational program with polyvitamins.